The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of three research awards through its Biomedical Innovation Program. The program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health.
The Biomedical Innovation Program is a collaboration between OCTRI and OHSU Technology Transfer and Business Development (TTBD). It is supported by major funding from OCTRI, and institutional support from OHSU, with additional support from Oregon Translational Research and Development Institute (OTRADI).
Congratulations to our 2015 Biomedical Innovation Pilot Award winners:
Eliminating retained surgical items using an embedded detector system
Remote endarterectomy device
Developing novel bioconjugates for the detection and treatment of bladder disease
“The principal goal of the Biomedical Innovation Program is to to accelerate innovation at OHSU by providing faculty with the funding, mentorship and project management necessary to develop their ideas for new biomedical devices and diagnostics,” said Eric Orwoll, M.D., professor of Medicine. “Our 2015 awardees represent the spirit of innovation at OHSU and we are very excited to work with them as they move their technologies toward commercialization.”
Detailed information on all three awards, including project abstracts, is provided on the OCTRI Pilot Project Awards webpage.
To learn more about OCTRI services and support, please visit www.octri.org
OCTRI is supported by (UL1TR000128) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH).